KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $964.7 million.

  • Exact Sciences' Cash & Current Investments fell 706.29% to $964.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $964.7 million, marking a year-over-year decrease of 706.29%. This contributed to the annual value of $964.7 million for FY2025, which is 706.29% down from last year.
  • Latest data reveals that Exact Sciences reported Cash & Current Investments of $964.7 million as of Q4 2025, which was down 706.29% from $1.0 billion recorded in Q3 2025.
  • Exact Sciences' Cash & Current Investments' 5-year high stood at $1.4 billion during Q1 2021, with a 5-year trough of $632.1 million in Q4 2022.
  • For the 5-year period, Exact Sciences' Cash & Current Investments averaged around $901.9 million, with its median value being $837.7 million (2022).
  • Per our database at Business Quant, Exact Sciences' Cash & Current Investments crashed by 4508.56% in 2022 and then soared by 3904.18% in 2024.
  • Exact Sciences' Cash & Current Investments (Quarter) stood at $1.0 billion in 2021, then plummeted by 38.66% to $632.1 million in 2022, then increased by 23.03% to $777.6 million in 2023, then skyrocketed by 33.48% to $1.0 billion in 2024, then fell by 7.06% to $964.7 million in 2025.
  • Its Cash & Current Investments was $964.7 million in Q4 2025, compared to $1.0 billion in Q3 2025 and $858.4 million in Q2 2025.